Literature DB >> 8388149

Striatonigral involvement following transient focal cerebral ischemia in the rats: an immunohistochemical study on a reversible ischemia model.

S Goto1, S Nagahiro, K Korematsu, Y Ushio.   

Abstract

A topographical and cellular immunohistochemical analysis was performed on the striatonigral system of rats with unilateral, reversible middle cerebral artery (MCA) occlusion. Antibodies to calcineurin (CaN), parvalbumin (PV), choline acetyltransferase (ChAT) and glial fibrillary acidic protein (GFAP) were used in this study. Sixty days after the operation, the ipsilateral striatum showed a characteristic cell type-specific injury in the dorsolateral part of the nucleus (i.e., non-limbic striatum): a marked reduction in the number of medium-sized spinous neurons expressing CaN immunoreactivity and a selective sparing of PV- and ChAT-positive interneurons. There was also a marked depletion of striatonigral afferents visualized by CaN immunostaining in the lateral portion of the substantia nigra pars reticulata, which is considered to be implicated with motor function. In addition, it was noted that such striatonigral involvement was accompanied by marked gliosis showing strong GFAP immunolabeling. The present data suggest that rats with reversible MCA occlusion can be a useful animal model for studying cell type-specific ischemic injury and subdivisional involvement of the striatonigral pathway as a part of the cortico-subcortical loop subserving motor function.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8388149     DOI: 10.1007/bf00230491

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  29 in total

1.  Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea.

Authors:  J T Coyle; R Schwarcz
Journal:  Nature       Date:  1976-09-16       Impact factor: 49.962

2.  Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic and kainic acids.

Authors:  E G McGeer; P L McGeer
Journal:  Nature       Date:  1976-10-07       Impact factor: 49.962

Review 3.  Glutamate and the pathophysiology of hypoxic--ischemic brain damage.

Authors:  S M Rothman; J W Olney
Journal:  Ann Neurol       Date:  1986-02       Impact factor: 10.422

4.  Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid.

Authors:  M F Beal; N W Kowall; D W Ellison; M F Mazurek; K J Swartz; J B Martin
Journal:  Nature       Date:  1986 May 8-14       Impact factor: 49.962

5.  Morphological characterization of the rat striatal neurons expressing calcineurin immunoreactivity.

Authors:  S Goto; Y Matsukado; E Miyamoto; M Yamada
Journal:  Neuroscience       Date:  1987-07       Impact factor: 3.590

6.  Immunohistochemical study of the striatal efferents and nigral dopaminergic neurons in parkinsonism-dementia complex on Guam in comparison with those in Parkinson's and Alzheimer's diseases.

Authors:  S Goto; A Hirano; S Matsumoto
Journal:  Ann Neurol       Date:  1990-05       Impact factor: 10.422

7.  The striatonigral degenerations. Putaminal pigments and nosology.

Authors:  A Borit; L J Rubinstein; H Urich
Journal:  Brain       Date:  1975-03       Impact factor: 13.501

8.  The neostriatal mosaic: compartmental distribution of calcium-binding protein and parvalbumin in the basal ganglia of the rat and monkey.

Authors:  C R Gerfen; K G Baimbridge; J J Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

9.  Sparing of acetylcholinesterase-containing striatal neurons in Huntington's disease.

Authors:  R J Ferrante; M F Beal; N W Kowall; E P Richardson; J B Martin
Journal:  Brain Res       Date:  1987-05-12       Impact factor: 3.252

10.  Reversible middle cerebral artery occlusion without craniectomy in rats.

Authors:  E Z Longa; P R Weinstein; S Carlson; R Cummins
Journal:  Stroke       Date:  1989-01       Impact factor: 7.914

View more
  8 in total

1.  Time dependent changes of striatal interneurons after focal cerebral ischemia in rats.

Authors:  M Sakuma; N Hyakawa; H Kato; T Araki
Journal:  J Neural Transm (Vienna)       Date:  2008-02-26       Impact factor: 3.575

2.  N-methyl-D-aspartate receptor antagonist MK-801 induced circling behavior in rats with unilateral striatal ischemic lesions or nigral 6-hydroxydopamine lesions.

Authors:  S Goto; K Korematsu; N Inoue; K Yamada; T Oyama; S Nagahiro; Y Ushio
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

3.  In vivo induction of the growth associated protein GAP43/B-50 in rat astrocytes following transient middle cerebral artery occlusion.

Authors:  K Yamada; S Goto; T Oyama; N Inoue; S Nagahiro; Y Ushio
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

4.  Subdivisional ischemic injury of the unilateral striatum causes apomorphine-induced rotational behavior in rats.

Authors:  S Goto; S Nagahiro; K Korematsu; K Kogo; Y Ushio
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

5.  Distinct neuronal subset reveals perikaryal immunostaining for synaptophysin (protein p38) in the striatum of rats.

Authors:  S Goto; K Korematsu; S Nagahiro; Y Ushio
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

6.  Melatonin ameliorates injury and specific responses of ischemic striatal neurons in rats.

Authors:  Yuxin Ma; Qiqi Feng; Jing Ma; Zhibo Feng; Mali Zhan; Lisi Ouyang; Shuhua Mu; Bingbing Liu; Zhuyi Jiang; Yu Jia; Youlan Li; Wanlong Lei
Journal:  J Histochem Cytochem       Date:  2013-05-16       Impact factor: 2.479

7.  Elevated immunoreactivity for glutamic acid decarboxylase in the rat cerebral cortex following transient middle cerebral artery occlusion.

Authors:  K Yamada; S Goto; T Oyama; N Inoue; S Nagahiro; Y Ushio
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

8.  Striatal cells containing the Ca(2+)-binding protein calretinin (protein 10) in ischemia-induced neuronal injury.

Authors:  K Yamada; S Goto; T Oyama; M Yoshikawa; S Nagahiro; Y Ushio
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.